← Leaderboards
S C Schulz
Case Western Reserve University
$76,796
Attributed
$76,796
Total exposure
4
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$76,796 · 4
By mechanism
M01$76,796 · 4
Top collaborators
No co-investigators on record.
Most similar at Case Western Reserve University
Same institution · by research overlap
- Scot C Remick$11,938,221
- Jeffrey L Blumer$4,676,143
- Martha X Sajatovic$17,916,099
- Robert L Findling$16,428,028
- Michael Marcel Lederman$51,371,852
Others in their field
Top investigators on “Antipsychotic Agents”
- P Jeffrey Conn · Vanderbilt University$24,634,463
- Abraham Aizer Brody · New York University School Of Medicine$22,358,187
- Constantine G Lyketsos · Johns Hopkins University$14,554,427
- John H Krystal · Yale University$14,263,729
- Dilip V Jeste · University Of California San Diego$13,885,388
- Thomas Scott Stroup · University Of North Carolina Chapel Hill$12,935,020
Research focus
Antipsychotic AgentsClinical ResearchDrug Screening /EvaluationHuman SubjectMental Disorder ChemotherapyRisperidoneHuman Therapy EvaluationSchizophreniaOutcomes ResearchDrug Adverse EffectDrug WithdrawalRelapse /RecurrenceHaloperidolHuman MorbidityQuality Of LifeClinical Trials
Grant awards (4)
RESPERIDONE VS HALOPERIDOL ON THE LONG TERM MORBIDITY OF EARLY PSYCHOTIC PTS$19,199
M01 · FY2000 · RR
CROSS TITRATION OF ANTIPSYCHOTICS W/ ZIPRASIDONE IN SUBJECTS W/ SCHIZOPHRENIA$19,199
M01 · FY2000 · RR
RISPERIDONE VS OLANZAPINE IN TX OF SCHIZOPHRENIA$19,199
M01 · FY2000 · RR
QUETIAPINE EXPERIENCE W/ SAFETY &TOLERABILITY (QUEST)$19,199
M01 · FY2000 · RR